Sixty consecutive patients with Stage I11 or bulky Stage II nonseminatous germinal testis tumors were treated with cisplatin, vinblastine, bleomycin combination chemotherapy (PVB). One patient died of acute toxicity after the first course of therapy, 16 entered complete remission (CR) after two or t
Neoadjuvant chemotherapy with cisplatin, vincristine, and bleomycin and radical surgery in early-stage bulky cervical carcinoma
β Scribed by Horng-Chyi Chang; Chyong-Huey Lai; Paul C. Chou; Chih-Jen Tseng; Ting-Chang Chang; Swei Hsueh; Yat-Sen Ho; Yung-Kuei Soong
- Publisher
- Springer
- Year
- 1992
- Tongue
- English
- Weight
- 557 KB
- Volume
- 30
- Category
- Article
- ISSN
- 0344-5704
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
A combination of cisplatin, methotrexate, bleomycin, and vincristine (CABO) was assessed in advanced epidermoid head and neck cancer. Among 72 patients with recurrent or metastatic disease and measurable lesions, there were 9 complete and 27 partial responses for an overall response rate of 50%. The
## For the EORTC Head and Neck Cooperative Group A total of 185 eligible patients with advanced inoperable squamous cell carcinoma of the head and neck were randomized into two groups; the cisplatin, methotrexate, bleomycin, and vincristine (CABO) group received cisplatin (50 mg/m2; day 4), methot
## BACKGROUND. The locoregional failure rate remains high in advanced cervical carcinoma. Chemotherapy (CT) was added to radiotherapy (RT) in order to increase disease control and to improve 5-year survival. ## METHODS. CT+RT included cisplatin administered 100 mg/mz, d.1 plus 5-flUOrOuracil 10
53 patients were treated with cisplatinvinblastine-bleomycin chemotherapy because of advanced nonseminomatous testicular tumor (NSTT). After the chemotherapy, the serum tumor markers were back to normal in 41 patients, of whom 35 were eligible for surgical removal of the residual tumor. In four pati